Emotional speech markers of psychiatric disturbance in Huntington’s disease
Frontiers in Psychiatry · 12.08.2025 · 16
DOI: 10.3389/fpsyt.2025.1633492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 12.08.2025. Verfasst von Lucie Chenain und 6 weiteren Autor:innen. Beteiligte Einrichtung: NeuroPsychologie Interventionnelle, Département d'Etudes Cognitives, Ecole Normale Supérieure, Paris Sciences et Lettres University, Paris, France. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Psychiatric disorders and difficulties in emotional expression represent a major problem in the management of Huntington’s Disease (HD). To improve patient follow-up, we propose to investigate the link between emotional expression and psychiatric symptoms, measured by the Problem Behaviors Assessment (PBA) scale. To this aim we developed the first emotional/psychiatric speech corpus, emoHD.
Methods
We included 102 HD gene carriers and 35 healthy controls (HC). Psychiatric symptoms were assessed using PBA sub-scales for Depression, Irritability/aggressivity, Apathy, and Obsessive/compulsive symptoms. Speech was annotated using three emotional descriptors: primary emotions, affective phenomena, and activation levels. Affective phenomena labels were selected based on PBA statements by external participants unaware of the study’s aims. We analyzed (1) emotional descriptors’ relationships, (2) emotional expression differences between HD and HC, and (3) the associations between emotions and psychiatric symptoms.
Results
HD patients showed reduced emotional expressiveness than HC with more neutral activation levels (=0). Only the primary emotion “angry” was less expressed in HD compared to HC. In contrast they expressed more affective phenomena states like apathetic, confused, “depressed”, “disoriented”, “frustrated”, and “pessimistic” than HC, whereas they expressed less “other” and “irritable” than HC. Expressed emotions were congruent with psychiatric symptoms (e.g., “anxious” and “nervous” are positively associated with Depression PBA sub-scale; “frustrated” with Irritability/aggressivity PBA sub-scale).
Conclusion
We showed that speech is a promising marker for emotional/psychiatric symptoms in HD, supporting future remote monitoring and personalized care strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NeuroPsychologie Interventionnelle, Département d'Etudes Cognitives, Ecole Normale Supérieure, Paris Sciences et Lettres University, Paris, France.
- NeuroPsychologie Interventionnelle, Université Paris Est Créteil, Institut national de la santé et de la recherche médicale (INSERM) Unité 955, Institut Mondor de Recherche Biomédicale, Créteil, France.
- Automatic Language Modelling and Analysis & Computational Humanities (ALMAnaCH), Institut national de recherche en sciences et technologies du numérique (INRIA), Paris, France.
- NeurATRIS, Hôpital Henri Mondor, Créteil, France.
- Learning Planet Institute, Université Paris Cité, Paris, France.
- Assistance Publique - Hôpitaux de Paris (AP-HP), Hôpital Henri Mondor-Albert Chenevier, Centre de Référence Maladie de Huntington, Service de Neurologie, Créteil, France.
Zitieren
APA
Chenain, L., Fabre, A., Titeux, H., Morgado, G., Youssov, K., Clavel, C., & Bachoud-Lévi, A. C. (2025). Emotional speech markers of psychiatric disturbance in Huntington’s disease. Frontiers in Psychiatry, 16. https://doi.org/10.3389/fpsyt.2025.1633492
Vancouver
Chenain L, Fabre A, Titeux H, Morgado G, Youssov K, Clavel C, et al. Emotional speech markers of psychiatric disturbance in Huntington’s disease. Frontiers in Psychiatry. 2025;16. doi:10.3389/fpsyt.2025.1633492
BibTeX
@article{Chenain2025,
author = {Chenain, Lucie and Fabre, Audrey and Titeux, Hadrien and Morgado, Graça and Youssov, Katia and Clavel, Chloé and Bachoud-Lévi, Anne-Catherine},
title = {Emotional speech markers of psychiatric disturbance in Huntington’s disease},
journal = {Frontiers in Psychiatry},
year = {2025},
volume = {16},
doi = {10.3389/fpsyt.2025.1633492}
}
EUVIMED